vs
RPC INC（RES）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是RPC INC的1.5倍（$622.0M vs $425.8M），Royalty Pharma plc净利率更高（34.4% vs -0.7%，领先35.2%），RPC INC同比增速更快（27.0% vs 4.8%），过去两年RPC INC的营收复合增速更高（6.2% vs 4.6%）
RPC集团是总部位于英国的企业，曾是欧洲规模最大的塑料包装供应商之一，总部坐落于北安普敦郡的拉什登。该公司此前在伦敦证券交易所上市，2019年被贝瑞全球集团收购，贝瑞全球集团又于2025年被安海斯包装收购。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
RES vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.5倍
$425.8M
营收增速更快
RES
高出22.2%
4.8%
净利率更高
RPRX
高出35.2%
-0.7%
两年增速更快
RES
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $425.8M | $622.0M |
| 净利润 | $-3.1M | $214.2M |
| 毛利率 | 21.0% | — |
| 营业利润率 | -0.9% | 62.4% |
| 净利率 | -0.7% | 34.4% |
| 营收同比 | 27.0% | 4.8% |
| 净利润同比 | -124.0% | 2.9% |
| 每股收益（稀释后） | $-0.02 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RESRPRX
| Q4 25 | $425.8M | $622.0M | ||
| Q3 25 | $447.1M | $609.3M | ||
| Q2 25 | $420.8M | $578.7M | ||
| Q1 25 | $332.9M | $568.2M | ||
| Q4 24 | $335.4M | $593.6M | ||
| Q3 24 | $337.7M | $564.7M | ||
| Q2 24 | $364.2M | $537.3M | ||
| Q1 24 | $377.8M | $568.0M |
净利润RESRPRX
| Q4 25 | $-3.1M | $214.2M | ||
| Q3 25 | $13.0M | $288.2M | ||
| Q2 25 | $10.1M | $30.2M | ||
| Q1 25 | $12.0M | $238.3M | ||
| Q4 24 | $12.8M | $208.2M | ||
| Q3 24 | $18.8M | $544.0M | ||
| Q2 24 | $32.4M | $102.0M | ||
| Q1 24 | $27.5M | $4.8M |
毛利率RESRPRX
| Q4 25 | 21.0% | — | ||
| Q3 25 | 25.1% | — | ||
| Q2 25 | 24.5% | — | ||
| Q1 25 | 26.7% | — | ||
| Q4 24 | 25.4% | — | ||
| Q3 24 | 26.7% | — | ||
| Q2 24 | 28.0% | — | ||
| Q1 24 | 26.8% | — |
营业利润率RESRPRX
| Q4 25 | -0.9% | 62.4% | ||
| Q3 25 | 4.7% | 70.1% | ||
| Q2 25 | 3.7% | 36.3% | ||
| Q1 25 | 3.7% | 94.0% | ||
| Q4 24 | 3.1% | 60.9% | ||
| Q3 24 | 5.7% | — | ||
| Q2 24 | 9.7% | 50.2% | ||
| Q1 24 | 8.6% | -13.0% |
净利率RESRPRX
| Q4 25 | -0.7% | 34.4% | ||
| Q3 25 | 2.9% | 47.3% | ||
| Q2 25 | 2.4% | 5.2% | ||
| Q1 25 | 3.6% | 41.9% | ||
| Q4 24 | 3.8% | 35.1% | ||
| Q3 24 | 5.6% | 96.3% | ||
| Q2 24 | 8.9% | 19.0% | ||
| Q1 24 | 7.3% | 0.8% |
每股收益（稀释后）RESRPRX
| Q4 25 | $-0.02 | $0.49 | ||
| Q3 25 | $0.06 | $0.67 | ||
| Q2 25 | $0.05 | $0.07 | ||
| Q1 25 | $0.06 | $0.55 | ||
| Q4 24 | $0.06 | $0.46 | ||
| Q3 24 | $0.09 | $1.21 | ||
| Q2 24 | $0.15 | $0.23 | ||
| Q1 24 | $0.13 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $210.0M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $1.1B | $9.7B |
| 总资产 | $1.5B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资RESRPRX
| Q4 25 | $210.0M | $618.7M | ||
| Q3 25 | $163.5M | $938.9M | ||
| Q2 25 | $162.1M | $631.9M | ||
| Q1 25 | $326.7M | $1.1B | ||
| Q4 24 | $326.0M | $929.0M | ||
| Q3 24 | $276.9M | $950.1M | ||
| Q2 24 | $261.5M | $1.8B | ||
| Q1 24 | $212.2M | $843.0M |
总债务RESRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益RESRPRX
| Q4 25 | $1.1B | $9.7B | ||
| Q3 25 | $1.1B | $9.6B | ||
| Q2 25 | $1.1B | $9.5B | ||
| Q1 25 | $1.1B | $9.8B | ||
| Q4 24 | $1.1B | $10.3B | ||
| Q3 24 | $1.1B | $10.3B | ||
| Q2 24 | $1.1B | $9.8B | ||
| Q1 24 | $1.0B | $9.9B |
总资产RESRPRX
| Q4 25 | $1.5B | $19.6B | ||
| Q3 25 | $1.5B | $19.3B | ||
| Q2 25 | $1.5B | $18.3B | ||
| Q1 25 | $1.3B | $17.6B | ||
| Q4 24 | $1.4B | $18.2B | ||
| Q3 24 | $1.3B | $18.0B | ||
| Q2 24 | $1.3B | $17.7B | ||
| Q1 24 | $1.3B | $16.1B |
负债/权益比RESRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.9M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $31.2M | — |
| 自由现金流率自由现金流/营收 | 7.3% | — |
| 资本支出强度资本支出/营收 | 7.2% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | $52.9M | — |
8季度趋势，按日历期对齐
经营现金流RESRPRX
| Q4 25 | $61.9M | $827.1M | ||
| Q3 25 | $46.5M | $702.6M | ||
| Q2 25 | $53.1M | $364.0M | ||
| Q1 25 | $39.9M | $596.1M | ||
| Q4 24 | $94.2M | $742.5M | ||
| Q3 24 | $70.7M | $703.6M | ||
| Q2 24 | $127.9M | $658.2M | ||
| Q1 24 | $56.6M | $664.6M |
自由现金流RESRPRX
| Q4 25 | $31.2M | — | ||
| Q3 25 | $4.1M | — | ||
| Q2 25 | $10.0M | — | ||
| Q1 25 | $7.6M | — | ||
| Q4 24 | $53.7M | — | ||
| Q3 24 | $19.1M | — | ||
| Q2 24 | $52.9M | — | ||
| Q1 24 | $3.8M | — |
自由现金流率RESRPRX
| Q4 25 | 7.3% | — | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | 2.4% | — | ||
| Q1 25 | 2.3% | — | ||
| Q4 24 | 16.0% | — | ||
| Q3 24 | 5.6% | — | ||
| Q2 24 | 14.5% | — | ||
| Q1 24 | 1.0% | — |
资本支出强度RESRPRX
| Q4 25 | 7.2% | — | ||
| Q3 25 | 9.5% | — | ||
| Q2 25 | 10.2% | — | ||
| Q1 25 | 9.7% | — | ||
| Q4 24 | 12.1% | — | ||
| Q3 24 | 15.3% | — | ||
| Q2 24 | 20.6% | — | ||
| Q1 24 | 14.0% | — |
现金转化率RESRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | 3.59× | 2.44× | ||
| Q2 25 | 5.23× | 12.06× | ||
| Q1 25 | 3.31× | 2.50× | ||
| Q4 24 | 7.38× | 3.57× | ||
| Q3 24 | 3.76× | 1.29× | ||
| Q2 24 | 3.95× | 6.45× | ||
| Q1 24 | 2.06× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RES
| Technical Service | $405.2M | 95% |
| Other | $8.8M | 2% |
| Nitrogen | $6.6M | 2% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
